$0.02
$0.00 (0.00%)
End-of-day quote: 05/15/2024
OTCPK:NDEV
Novus Acquisition & Development Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| UNH | UnitedHealth Group | NYSE | Buy | $521.27 | $595.09 | 0.00% | 3 | $476.35B |
| ELV | Elevance Health | NYSE | Buy | $543.89 | $567.53 | 0.00% | 1 | $125.50B |
| CI | The Cigna Group | NYSE | Outperform | $339.26 | $354.48 | 0.00% | 2 | $97.52B |
| HUM | Humana | NYSE | Outperform | $355.19 | $426.74 | 0.00% | 1 | $41.83B |
| CNC | Centene | NYSE | Outperform | $77.14 | $88.33 | 0.00% | 11 | $41.67B |
| MOH | Molina Healthcare | NYSE | Outperform | $345.00 | $393.38 | 0.00% | 1 | $20.27B |
| GTS | Triple-S Management | NYSE | - | $35.98 | $19.00 | 0.00% | 0 | $836.01M |
| MRDH | Meridian Holdings | OTCPK | - | $0.03 | $0.00 | 0.00% | 0 | $3.81M |
| DPAT | Dental Patient Care America | OTCPK | - | $0.02 | $0.00 | 0.00% | 0 | $0.43M |
| CMP | Advanzeon Solutions | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.01M |
